Rolke James 4
4 · REVELATION BIOSCIENCES, INC. · Filed Feb 13, 2025
Insider Transaction Report
Form 4
Rolke James
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-02-11$3.87/sh+30,095$116,468→ 30,137 total
Holdings
- 42
Common Stock
Footnotes (1)
- [F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.